Skip to content

SHENGTAI PHARMACEUTICAL, INC.

CIK 0001295079

← back to feed
Revenue (TTM)
$202.38M
+4.3% YoY Q3 May 2013
Net Income (TTM)
$660.99K
−86.0% YoY Q3 May 2013
EPS Diluted (TTM)
—
Q3 May 2013
Gross Margin
10.8%
Q3 May 2013
Operating Margin
3.7%
Q3 May 2013
Net Margin
0.3%
Q3 May 2013
Free Cash Flow (TTM)
−$23.74M
Q3 May 2013
Cash
$7.71M
Q3 May 2013
Total Debt
$82.44M
Q3 May 2013
Shares Outstanding
9.58M sh
Q3 May 2013

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings